94% of participants maintained seroresponse five years after a single vaccination Comparable antibody persistence observed in older (65+) and younger adul...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced positive results from two Phase 2 trials of Shigella4V2 (S4V2), the ...
iDEL Therapeutics announced that it has entered into a research collaboration with Daiichi Sankyo (TSE: 4568) to utilize iDEL’s synthetic shuttl...
For patients living with Fabry disease, progressive kidney damage can lead to dialysis, transplantation and serious long-term complications. Idorsia is dev...
ALKIVIA met its primary and key secondary endpoints in the combined IMNM and DM population First Phase 3 study to demonstrate statistically significant an...
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmace...
The completed Phase 1a study data in healthy volunteers showed early signs of pharmacodynamic activity supporting further clinical evaluation of RES-010 T...
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration c...
ArrayPatch Ltd (“ArrayPatch”), a biotech company developing innovative microneedle-based therapeutics, announced the successful completion of t...
40-fold lower virus load compared to placebo on Day 2, at the peak of viral replication Exposure-response relationship observed, with greater interferon l...
Ambrose Healthcare’s acquisition of AM-Pharma, valued at up to €161 million plus royalties, strengthens its rare disease pipeline and establishe...
Lonza, a global contract development and manufacturing organization, to acquire the CDMO business of Merck Transaction sharpens the focus of Merck&rsq...
HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) announces that regulatory filings for ORPATHYS® (savolitinib) in combinati...
Bracco convened the second edition of the Global CEUS Steering Committee, bringing together international experts in contrast-enhanced ultrasound (CEUS) to...
© 2026 Biopharma Boardroom. All Rights Reserved.
